@cspramesh @ParikhSimul According to the NEJM for the number one cancer killer (lung) it’s medical oncology (for living longer) https://t.co/hVTuGBpJ4V.
@5_utr @CGrassberger @HenningWillers @PatrickCMa1 @PercyLeeMD @SalmaJabbour1 @SBRT_CR @BLoo_LT_SABR @TimothyKruserMD @abewu Notice my careful wording :) doubt the improvement in stage IV nsclc is VERY MUCH from RT Nay, not doubt I *know* stage IV surviva
@ManniMD1 @DrNikitaMehra @AaronGoodman33 @BlairDeStefano @rajshekharucms @HadidiSamer @Eddie_Cliff @Dr_AmerZeidan @sghmd @MyelomaAmateur @MyelomaTeacher The delay in action by these Medical Ivory Towers was so great, that it may have impacted the overall C
@tnewsomdavis @JackWestMD @PatelOncology @bradloncar @US_FDA Tom, do you think the delay (maybe perceived) in targeted therapy (& IO) availability has had an impact on population outcomes for NSCLC in UK? The use of targeted therapy/IO in US is being